Files and links (1)
Accepted (AM)Open Access (License Unspecified), Open
Journal article
Survival implications of prescription opioid and benzodiazepine use in lung transplant recipients: Analysis of linked transplant registry and pharmacy fill records
JOURNAL OF HEART AND LUNG TRANSPLANTATION, v 40(6), pp 513-524
Jun 2021
PMID: 33846078
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
BACKGROUND: Prescription opioid and benzodiazepine use have been associated with morbidity and mortality among some groups of solid organ transplant recipients, but implications for outcomes among lung transplant patients are not well described. METHODS: We conducted a retrospective cohort study using linked national transplant registry and pharmaceutical records to characterize the associations between benzodiazepine and opioid prescription fills in the years before and after lung transplant (2006-2017), with risk-adjusted posttransplant survival (adjusted hazard ratio, LCLaHRUCL). RESULTS: Among 11,568 recipients, 33.7% filled an opioid prescription, and 25.8% filled a benzodiazepine prescription before transplant. Compared to patients without prescriptions, those who filled both short- and long-acting benzodiazepine prescriptions before transplant had 2-fold higher mortality in the first year posttransplant (aHR, (1.39)2.12(3.21)), after adjustment for baseline factors and opioid fills, while pretransplant opioid fills were not associated with posttransplant mortality after adjustment for benzodiazepine fills. Pretransplant opioid and benzodiazepine use strongly predicted more use after transplant. Fills of both short- and long-acting benzodiazepines in the first year posttransplant were associated with 77% increased mortality >1-to-2 years posttransplant (aHR, (1.06)1.77(2.96)). Compared with no posttransplant opioid fills, there was a dose-dependent association between first-year opioid fills and subsequent adjusted mortality risk (level 2: aHR, (1.17)1.50(1.92) to level 4: aHR, (1.56)2.01(2.59)). These effects were independent, and interactions were not detected. CONCLUSIONS: Benzodiazepine prescription fills before and after lung transplant, and opioid fills after transplant, are independently associated with posttransplant mortality. Review of benzodiazepine and opioid use history is relevant to risk-stratifying patients before and after lung transplant. (C) 2021 International Society for Heart and Lung Transplantation. All rights reserved.
Metrics
Details
- Title
- Survival implications of prescription opioid and benzodiazepine use in lung transplant recipients: Analysis of linked transplant registry and pharmacy fill records
- Publication Details
- JOURNAL OF HEART AND LUNG TRANSPLANTATION, v 40(6), pp 513-524
- Publisher
- ELSEVIER SCIENCE INC; NEW YORK
- Number of pages
- 11
- Grant note
- This work was conducted under the auspices of the Hennepin Healthcare Research Institute, contractor for the Scientific Registry of Transplant Recipients (SRTR), as a deliverable under contract no. HHSH250201000018C (US Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation). The US Government (and others acting on its behalf) retains a paid-up, nonexclusive, irrevocable, worldwide license for all works produced under the SRTR contract and to reproduce them, prepare derivative works, distribute copies to the public, and perform publicly and display publicly, by or on behalf of the Government.r KLL, MDD, DLS, GPH, and MAS receive funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK120518. K.L.L. is supported by the Mid-America Transplant/Jane A. Beckman Endowed Chair in Transplantation. The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy of or interpretation by the SRTR or the US Government. The opinions, results, and conclusions reported in this article are those of the authors and are independent of the funding sources. An oral abstract describing portions of this work was presentated at the virtual American Transplant Congress, June 2020.
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Drexel University
- Web of Science ID
- WOS:000655667900014
- Scopus ID
- 2-s2.0-85103939617
- Other Identifier
- 991021860759704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Cardiac & Cardiovascular Systems
- Respiratory System
- Surgery
- Transplantation